- Home
- YJ vs HOTH Comparison
YJ vs HOTH Comparison
Compare YJ & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YJ
- HOTH
- Stock Information
- Founded
- YJ 2015
- HOTH 2017
- Country
- YJ China
- HOTH United States
- Employees
- YJ N/A
- HOTH N/A
- Industry
- YJ Other Specialty Stores
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- YJ Consumer Discretionary
- HOTH Health Care
- Exchange
- YJ Nasdaq
- HOTH Nasdaq
- Market Cap
- YJ 7.9M
- HOTH 7.6M
- IPO Year
- YJ 2019
- HOTH 2019
- Fundamental
- Price
- YJ $1.99
- HOTH $0.83
- Analyst Decision
- YJ
- HOTH Strong Buy
- Analyst Count
- YJ 0
- HOTH 4
- Target Price
- YJ N/A
- HOTH $4.75
- AVG Volume (30 Days)
- YJ 13.2K
- HOTH 2.0M
- Earning Date
- YJ 11-21-2024
- HOTH 11-12-2024
- Dividend Yield
- YJ N/A
- HOTH N/A
- EPS Growth
- YJ N/A
- HOTH N/A
- EPS
- YJ N/A
- HOTH N/A
- Revenue
- YJ $72,682,024.00
- HOTH N/A
- Revenue This Year
- YJ N/A
- HOTH N/A
- Revenue Next Year
- YJ N/A
- HOTH N/A
- P/E Ratio
- YJ N/A
- HOTH N/A
- Revenue Growth
- YJ N/A
- HOTH N/A
- 52 Week Low
- YJ $1.42
- HOTH $0.58
- 52 Week High
- YJ $4.72
- HOTH $1.73
- Technical
- Relative Strength Index (RSI)
- YJ 56.41
- HOTH 45.24
- Support Level
- YJ $1.45
- HOTH $0.78
- Resistance Level
- YJ $1.68
- HOTH $0.90
- Average True Range (ATR)
- YJ 0.17
- HOTH 0.06
- MACD
- YJ 0.04
- HOTH -0.01
- Stochastic Oscillator
- YJ 51.92
- HOTH 25.62
About YJ Yunji Inc. American Depository Shares
Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in China.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.